Peter Huypens

Peter Huypens

Auto-generated profile, based on publicly available information

Peter Huypens

Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2018 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
MKMaximilian Kleinert
Maximilian Kleinert
CCChristoffer Clemmensen
Christoffer Clemmensen
SHSusanna M. Hofmann
Susanna M. Hofmann
MMMary C. Moore
Mary C. Moore
SRSimone Renner
Simone Renner
MTMatthias H. Tschöp
Matthias H. Tschöp

1 November 1995 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AVA De Vos
A De Vos
HHH Heimberg
H Heimberg
EQE Quartier
E Quartier
PHP Huypens
P Huypens
LBL Bouwens
L Bouwens
FSF Schuit
F Schuit
Glucose homeostasis is controlled by a glucose sensor in pancreatic beta-cells. Studies on rodent beta-cells have suggested a role for GLUT2 and glucokinase in this control function and in mechanisms leading to diabetes. Little direct evidence exists so far to implicate these two proteins in glucose recognition by human beta-cells. The present in vitro study investigates the role of glucose transport and phosphorylation in beta-cell preparations from nondiabetic human pancreata. Human beta-cells differ from rodent beta-cells in glucose transporter gene expression (predominantly GLUT1 instead of GLUT2), explaining their low Km (3 mmol/liter) and low VMAX (3 mmol/min per liter) for 3-O-methyl glucose transport. The 100-fold lower GLUT2 abundance in human versus rat beta-cells is associated with a 10-fold slower uptake of alloxan, explaining their resistance to this rodent diabetogenic agent. Human and rat beta-cells exhibit comparable glucokinase expression with similar flux-generating influence on total glucose utilization. These data underline the importance of glucokinase but not of GLUT2 in the glucose sensor of human beta-cells.

14 March 2016 in Nature Genetics
Verified
Journal Article
Closed access
PHPeter Huypens
Peter Huypens
SSSteffen Sass
Steffen Sass
MWMoya Wu
Moya Wu
DDDaniela Dyckhoff
Daniela Dyckhoff
MTMatthias Tschöp
Matthias Tschöp
JBJohannes Beckers
Johannes Beckers

1 January 2001 in Diabetes
Verified
Journal Article
Open access
PDF file
FSFrans C. Schuit
Frans C. Schuit
PHPeter Huypens
Peter Huypens
HHHarry Heimberg
Harry Heimberg
DPDaniel G. Pipeleers
Daniel G. Pipeleers
Nutrient homeostasis is known to be regulated by pancreatic islet tissue. The function of islet β-cells is controlled by a glucose sensor that operates at physiological glucose concentrations and acts in synergy with signals that integrate messages originating from hypothalamic neurons and endocrine cells in gut and pancreas. Evidence exists that the extrapancreatic cells producing and secreting these (neuro)endocrine signals also exhibit a glucose sensor and an ability to integrate nutrient and (neuro)hormonal messages. Similarities in these cellular and molecular pathways provide a basis for a network of coordinated functions between distant cell groups, which is necessary for an appropriate control of nutrient homeostasis. The glucose sensor seems to be a fundamental component of these control mechanisms. Its molecular characterization is most advanced in pancreatic β-cells, with important roles for glucokinase and mitochondrial oxidative fluxes in the regulation of ATP-sensitive K+ channels. Other glucose-sensitive cells in the endocrine pancreas, hypothalamus, and gut were found to share some of these molecular characteristics. We propose that similar metabolic signaling pathways influence the function of pancreatic α-cells, hypothalamic neurons, and gastrointestinal endocrine and neural cells.

1 September 2010 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
PDF file
BHBarbara E. Hasek
Barbara E. Hasek
LSLaura K. Stewart
Laura K. Stewart
THTara M Henagan
Tara M Henagan
ABAnik Boudreau
Anik Boudreau
NLNatalie R. Lenard
Natalie R. Lenard
TGThomas W. Gettys
Thomas W. Gettys
Dietary methionine restriction (MR) is a mimetic of chronic dietary restriction (DR) in the sense that MR increases rodent longevity, but without food restriction. We report here that MR also persistently increases total energy expenditure (EE) and limits fat deposition despite increasing weight-specific food consumption. In Fischer 344 (F344) rats consuming control or MR diets for 3, 9, and 20 mo, mean EE was 1.5-fold higher in MR vs. control rats, primarily due to higher EE during the night at all ages. The day-to-night transition produced a twofold higher heat increment of feeding (3.0°C vs. 1.5°C) in MR vs. controls and an exaggerated increase in respiratory quotient (RQ) to values greater than 1, indicative of the interconversion of glucose to lipid by de novo lipogenesis. The simultaneous inhibition of glucose utilization and shift to fat oxidation during the day was also more complete in MR (RQ ∼0.75) vs. controls (RQ ∼0.85). Dietary MR produced a rapid and persistent increase in uncoupling protein 1 expression in brown (BAT) and white adipose tissue (WAT) in conjunction with decreased leptin and increased adiponectin levels in serum, suggesting that remodeling of the metabolic and endocrine function of adipose tissue may have an important role in the overall increase in EE. We conclude that the hyperphagic response to dietary MR is matched to a coordinated increase in uncoupled respiration, suggesting the engagement of a nutrient-sensing mechanism, which compensates for limited methionine through integrated effects on energy homeostasis.

9 August 2000 in Diabetologia
Verified
Journal Article
Open access
PDF file
PHP. Huypens
P. Huypens
ZLZ. Ling
Z. Ling
DPD. Pipeleers
D. Pipeleers
FSF. Schuit
F. Schuit
Aims/hypothesis. Synergism between glucose and cAMP in the stimulation of insulin secretion has been suggested to regulate beta cells. This study assessed the importance of an interaction between glucose and cAMP in the stimulation of insulin secretion from human islet cells by investigating expression and functional activity of receptors recognising glucagon, glucagon-like peptide-1 (7–36)amide (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Methods. Expression of the glucagon, GLP-1 and GIP receptors in human islets was investigated by northern blots and reverse transcription-polymerase chain reaction analysis. Functional activity of these receptors was assessed by the effects of peptides (agonists and antagonists) on glucose-induced insulin release. Results. Human islet cells express transcripts encoding glucagon, GLP-1 and GIP receptors. Glucose (10 mmol/l) stimulated insulin release 4.5 ± 0.6-fold over basal (2.5 mmol/l). This glucose effect was amplified by 10 nmol/l GLP-1, GIP or glucagon. It was reduced by 51 ± 6 % in the presence of 1 μmol/l of the glucagon-receptor antagonist des-His1-[Glu9]-glucagon-amide (n = 8; p < 0.05), indicating participation of endogenously released glucagon in the process of glucose-induced insulin release. The glucagon-receptor antagonist also suppressed the potentiation of glucose-induced insulin release by addition of 10 nmol/l glucagon. Conclusion/interpretation. These data suggest that human beta cells express functional glucagon receptors which can, similar to incretin hormone receptors, generate synergistic signals for glucose-induced insulin secretion. [Diabetologia (2000) 43: 1012–1019]